DK0788512T3 - Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes - Google Patents

Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes

Info

Publication number
DK0788512T3
DK0788512T3 DK95926642T DK95926642T DK0788512T3 DK 0788512 T3 DK0788512 T3 DK 0788512T3 DK 95926642 T DK95926642 T DK 95926642T DK 95926642 T DK95926642 T DK 95926642T DK 0788512 T3 DK0788512 T3 DK 0788512T3
Authority
DK
Denmark
Prior art keywords
proinsulin
type
diabetes
peptide compounds
proinsulin peptide
Prior art date
Application number
DK95926642T
Other languages
English (en)
Inventor
William F Hickey
Ann C Griffin
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26955374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0788512(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of DK0788512T3 publication Critical patent/DK0788512T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
DK95926642T 1994-07-08 1995-07-07 Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes DK0788512T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27222094A 1994-07-08 1994-07-08
US47270495A 1995-06-06 1995-06-06
PCT/US1995/008596 WO1996001846A1 (en) 1994-07-08 1995-07-07 Proinsulin peptide compounds for detecting and treating type i diabetes

Publications (1)

Publication Number Publication Date
DK0788512T3 true DK0788512T3 (da) 1999-10-11

Family

ID=26955374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95926642T DK0788512T3 (da) 1994-07-08 1995-07-07 Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes

Country Status (12)

Country Link
US (1) US20030220229A1 (da)
EP (1) EP0788512B1 (da)
JP (1) JPH10505821A (da)
CN (1) CN1157621A (da)
AT (1) ATE178074T1 (da)
AU (1) AU3094795A (da)
CA (1) CA2194548A1 (da)
DE (1) DE69508605T2 (da)
DK (1) DK0788512T3 (da)
ES (1) ES2130629T3 (da)
MX (1) MX9700198A (da)
WO (1) WO1996001846A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289751T3 (es) 1995-02-20 2008-02-01 The Walter And Eliza Hall Institute Of Medical Research Moleculas inmunorreactivas e inmunoterapeuticas que interaccionan en sujetos con diabetes mellitus insulinodependientes (dmid).
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
AUPO269996A0 (en) * 1996-10-01 1996-10-24 Walter And Eliza Hall Institute Of Medical Research, The A method of prophylaxis and treatment
US7509406B2 (en) * 2004-09-30 2009-03-24 Microsoft Corporation Managing terminal services accounts and sessions for online utilization of a hosted application
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
CN103630692B (zh) * 2013-06-02 2015-05-06 马鞍山国声生物技术有限公司 快速检测尿液c肽的胶体金免疫层析试剂盒及其检测方法
KR102393711B1 (ko) * 2013-10-17 2022-05-04 더 제너럴 하스피탈 코포레이션 자가면역 질환의 치료에 반응하는 대상체의 식별 방법 및 그의 치료를 위한 조성물
GB2559499A (en) * 2014-02-25 2018-08-08 Orban Tihamer Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
GB2523399B (en) * 2014-02-25 2019-03-13 Orban Tihamer A composition comprising ten overlapping peptide fragments of the entire preproinsulin sequence

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210872B2 (da) * 1973-07-14 1977-03-26
US4308181A (en) * 1980-12-08 1981-12-29 American Home Products Corporation Polypeptide compositions
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
NL9001083A (nl) * 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
JP2649103B2 (ja) * 1990-08-17 1997-09-03 ユニバーシティー オブ フロリダ インシュリン依存性真性糖尿病の早期検出及び処置のための方法及び組成物

Also Published As

Publication number Publication date
ES2130629T3 (es) 1999-07-01
US20030220229A1 (en) 2003-11-27
WO1996001846A1 (en) 1996-01-25
EP0788512B1 (en) 1999-03-24
EP0788512A1 (en) 1997-08-13
DE69508605T2 (de) 1999-07-22
JPH10505821A (ja) 1998-06-09
CA2194548A1 (en) 1996-01-25
CN1157621A (zh) 1997-08-20
DE69508605D1 (de) 1999-04-29
MX9700198A (es) 1997-04-30
ATE178074T1 (de) 1999-04-15
AU3094795A (en) 1996-02-09

Similar Documents

Publication Publication Date Title
IT1195287B (it) Derivato tiazolico,procedimento per la sua preparazione e relative composizioni farmaceutiche
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ATE378418T1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
DK0682529T3 (da) Antistof til behandling af insulinkrævende diabetes
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
DK93685A (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
DK0788512T3 (da) Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes
NO851916L (no) Anordning for aa sperre en offshore-plattform i forhold til ben som baerer plattformen.
DE3784201D1 (de) Zusammensetzung fuer elektrophotographische entwickler.
NO930975D0 (no) Fuktighetsherdende en-komponent polysiloksanforbindelse
ATE13433T1 (de) Peptide als arzneimittel und einige peptide.
TR199800521T1 (xx) Se�imli beta3 adrenerjik agonistler.
ATE144529T1 (de) Beta-zell-antigen
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
FI971427A (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
WO1996001846B1 (en) Proinsulin peptide compounds for detecting and treating type i diabetes
DK361282A (da) Fremgangsmaade til fremstilling af o-alkyl-o-carbamoylglycerophosphocholiner
DK0972032T3 (da) Peptider til behandling af systemisk lupus erythematosus
DK198688D0 (da) Fremgangsmaade til maaling af polariserede fluorescensemissioner
DK265484A (da) Forbedret fremgangsmaade til fremstilling af steroidestere
DE69518246D1 (de) Aminosäuren konjugaten
DK0646016T3 (da) Syntetiske peptider til behandlling af myasthenia gravis
ATE216386T1 (de) Kv2.1 antagonisten